Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
- Sep 7, 2021
- 1 min
Successful Placement in Times Higher Education Rankings
- Sep 4, 2021
- 4 min
The Hope and Promise of Immuno-Oncology
- Sep 1, 2021
- 3 min
Innovative Drug Discovery
- Aug 30, 2021
- 1 min
Spotlight on Internationalisation
- Aug 30, 2021
- 1 min
New Member: Welcome in our cluster to btS – Life Sciences Studierendeninitiative e.V.
- Aug 29, 2021
- 2 min
Superspreading events as drivers of SARS-CoV-2 evolution
- Aug 24, 2021
- 4 min
Peer Bork honoured with Novozymes Prize and ISCB Senior Scientist Award
- Aug 24, 2021
- 3 min
Blood-based micro-RNAs indicate the risk of colorectal cancer
- Aug 24, 2021
- 2 min
MASSIF-1 beamline in Grenoble supports COVID-19 drug discovery
- Aug 24, 2021
- 4 min
How much does it cost to research & develop a new drug?
- Aug 23, 2021
- 1 min
New Member: Welcome in our cluster to Anavo Therapeutics
- Aug 16, 2021
- 4 min
Heidelberg is calling for life sciences start-ups
- Aug 13, 2021
- 1 min
BioRN Support for the new Innovation Campus Health & Life Science
- Aug 11, 2021
- 2 min
BioMed X Institute announces two new research groups in collaboration with Janssen